A Study in Subjects With Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT03175354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of ALX-101 Gel 1.5% and 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily for 42 days to adult and adolescent subjects with moderate atopic dermatitis.
Study identification
- NCT ID
- NCT03175354
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 209 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2017 (Actual)
- Primary completion
- Jun 29, 2018 (Actual)
- Completion
- Jun 29, 2018 (Actual)
- Last update posted
- Oct 25, 2018
2017 – 2018
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ralexar Investigational Site 35 | Anniston | Alabama | 36207 | — |
| Ralexar Investigational Site 21 | Birmingham | Alabama | 35209 | — |
| Ralexar Investigational Site 18 | Laguna Hills | California | 92653 | — |
| Ralexar Investigational Site 23 | Los Angeles | California | 90045 | — |
| Ralexar Investigational Site 24 | Oceanside | California | 92056 | — |
| Ralexar Investigational Site 34 | San Diego | California | 92103 | — |
| Ralexar Investigational Site 16 | San Diego | California | 92108 | — |
| Ralexar Investigational Site 33 | San Diego | California | 92121 | — |
| Ralexar Investigational Site 27 | Santa Monica | California | 90404 | — |
| Ralexar Investigational Site 1 | Miami | Florida | 33143 | — |
| Ralexar Investigational Site 14 | Pinellas Park | Florida | 33781 | — |
| Ralexar Investigational Site 22 | Tampa | Florida | 33618 | — |
| Ralexar Investigational Site 29 | Snellville | Georgia | 30078 | — |
| Ralexar Investigational Site 17 | New Albany | Indiana | 47150 | — |
| Ralexar Investigational Site 32 | Louisville | Kentucky | 40202 | — |
| Ralexar Investigational Site 7 | Louisville | Kentucky | 40241 | — |
| Ralexar Investigational Site 11 | Warren | Michigan | 48088 | — |
| Ralexar Investigational Site 15 | Fridley | Minnesota | 55432 | — |
| Ralexar Investigational Site 25 | Saint Joseph | Missouri | 64506 | — |
| Ralexar Investigational Site 26 | Albuquerque | New Mexico | 87106 | — |
| Ralexar Investigational Site 20 | New York | New York | 10075 | — |
| Ralexar Investigational Site 30 | Stony Brook | New York | 11790 | — |
| Ralexar Investigational Site 28 | Charlotte | North Carolina | 28217 | — |
| Ralexar Investigational Site 12 | Beachwood | Ohio | 44122 | — |
| Ralexar Investigational Site 5 | Cincinnati | Ohio | 45236 | — |
| Ralexar Investigational Site 3 | Oklahoma City | Oklahoma | 73112 | — |
| Ralexar Investigational Site 8 | Johnston | Rhode Island | 02919 | — |
| Ralexar Investigational Site 6 | Spartanburg | South Carolina | 29303 | — |
| Ralexar Investigational Site 9 | Nashville | Tennessee | 37215 | — |
| Ralexar Investigational Site 19 | Austin | Texas | 78745 | — |
| Ralexar Investigational Site 31 | Austin | Texas | 78759 | — |
| Ralexar Investigational Site 4 | Plano | Texas | 75024 | — |
| Ralexar Investigational Site 2 | San Antonio | Texas | 78218 | — |
| Ralexar Investigational Site 13 | Richmond | Virginia | 23220 | — |
| Ralexar Investigational Site 10 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03175354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2018 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03175354 live on ClinicalTrials.gov.